Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Aug 3, 2026
- Incorporated
- Delaware
- Filings on record
- 414 filings
- On EDGAR
- CIK 1796280
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 26
News 8 of 64
Prospectuses and Registrations 8 of 24
- S-8 Registration statement for an employee plan Jul 30, 2026
- 424B5 Prospectus supplement for an offering Feb 23, 2026
- S-8 Registration statement for an employee plan Feb 23, 2026
- 424B3 Prospectus supplement for an offering Jun 24, 2025
- S-3 Shelf registration statement Jun 11, 2025
- S-8 Registration statement for an employee plan Mar 20, 2025
- S-8 Registration statement for an employee plan Mar 29, 2024
- S-3ASR Automatic shelf registration Mar 11, 2024
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFA14A Extra proxy material Apr 26, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2023
Ownership 8 of 245
- 4 Insider reported a trade Jul 28, 2026
- 4 Insider reported a trade Jul 8, 2026
- 144 Notice of a proposed sale of restricted stock Jul 6, 2026
- 144 Notice of a proposed sale of restricted stock Jul 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
Other 8 of 43
- ARS Annual report sent to shareholders Apr 28, 2026
- EFFECT Notice that a registration became effective Jun 20, 2025
- CORRESP Reply to SEC staff Jun 17, 2025
- UPLOAD Comment letter from SEC staff Jun 16, 2025
- D Jun 6, 2025
- ARS Annual report sent to shareholders Apr 23, 2025
- ARS Annual report sent to shareholders Apr 24, 2024
- EFFECT Notice that a registration became effective Feb 2, 2024
Everything here comes from Oric Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.